Cell therapy for neonatal hypoxic-ischemic encephalopathy

Stem Cells and Development
Pedro M Pimentel-Coelho, Rosalia Mendez-Otero

Abstract

Neonatal hypoxic-ischemic encephalopathy (HIE) is a common cause of long-term neurological disability in children. Despite advances in supportive care, no treatments for HIE are available at present. The potential use of stem/progenitor cell therapies for neuroprotection or regeneration of the damaged adult brain has been evaluated in several preclinical studies, and the most promising results are now being tested in clinical trials. In recent years, the use of stem/progenitor cell transplantation in animal models of HIE has also been evaluated in several laboratories. It was shown that human umbilical cord blood mononuclear cells and mesenchymal stem/progenitor cells may have a therapeutic potential through multiple mechanisms acting locally in the central nervous system and possibly in peripheral organs of hypoxic-ischemic animals. Neural stem/progenitor cells (NSCs) have also been transplanted in animal models of HIE, migrating long distances to ischemic brain areas and differentiating into neurons. The results of these studies have raised important questions that must be addressed before these findings can be translated to the bedside. In this review, we give a critical overview of the different studies published up to now,...Continue Reading

References

Jan 1, 1996·Experimental Neurology·M H ElsayedA J Castro
Dec 4, 1998·BMJ : British Medical Journal·N BadawiF J Stanley
Dec 6, 2001·Journal of Child Neurology·M E DilengeM I Shevell
Mar 3, 2004·Proceedings of the National Academy of Sciences of the United States of America·Muriel AsheuerNathalie Cartier
Jul 21, 2004·Neurobiology of Disease·Jennifer M PlaneJack M Parent
Sep 4, 2004·Stroke; a Journal of Cerebral Circulation·Cesar V BorlonganPaul R Sanberg
Dec 21, 2004·Proceedings of the National Academy of Sciences of the United States of America·Jaime ImitolaSamia J Khoury
Mar 9, 2005·Lancet·Joy E LawnUNKNOWN Lancet Neonatal Survival Steering Team
Apr 23, 2005·American Journal of Obstetrics and Gynecology·Shinji KatsuragiTsuyomu Ikenoue
May 3, 2005·Neuroscience Letters·Cun-Gang FanZhong-Chao Han
Jun 23, 2005·Stem Cells and Development·Nagwa S El-Badri
Nov 25, 2005·Stem Cells and Development·Martina VendrameAlison E Willing
Dec 24, 2005·Nature Reviews. Neuroscience·Franz-Josef MüllerJeanne F Loring
Apr 6, 2006·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Li Hong ShenMichael Chopp
Apr 21, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Ryan J FellingSteven W Levison
May 11, 2006·Journal of Cell Science·Lindolfo da Silva MeirellesNance Beyer Nardi
May 23, 2006·Experimental Neurology·Martina VendrameAlison E Willing
May 27, 2006·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Meijing WangDaniel R Meldrum
Aug 24, 2006·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Lin QiuKlas Blomgren
Sep 19, 2006·Stem Cells and Development·Nagwa S El-BadriPaul R Sanberg
Feb 9, 2007·Annals of Neurology·Zhengang YangSteven W Levison
Jul 20, 2007·Regenerative Medicine·Rosalia Mendez-OteroJamary Oliveira-Filho
Dec 25, 2007·Brain : a Journal of Neurology·Soon-Tae LeeJae-Kyu Roh

❮ Previous
Next ❯

Citations

Sep 12, 2012·Bone Marrow Transplantation·Y LiaoM S Cairo
Mar 21, 2012·Pediatric Research·Cindy T J van VelthovenCobi J Heijnen
Oct 23, 2010·Stem Cells and Development·Luigi TitomanlioPierre Gressens
Mar 17, 2010·Stem Cells and Development·José R Borbolla-Escoboza
Jul 22, 2011·Stem Cells International·Serpen DurnaogluKursad Genc
Dec 14, 2011·International Journal of Pediatrics·Pia Wintermark
Jun 1, 2011·The EPMA Journal·Paola MoralesEdgardo Rojas-Mancilla
Sep 27, 2015·Neurobiology of Disease·Henrik HagbergFloris Groenendaal
Dec 14, 2011·Annals of Neurology·Luigi TitomanlioPierre Gressens
Jan 1, 2010·Developmental Disabilities Research Reviews·Alexander H Hoon, Andreia Vasconcellos Faria
Apr 1, 2016·Scientific Reports·Jeff M FortinBrent A Reynolds
Jul 2, 2014·BioMed Research International·Paulo Henrique Rosado-de-CastroLea Mirian Barbosa da Fonseca
Nov 11, 2011·American Journal of Obstetrics and Gynecology·Andreina SchoeberleinDaniel V Surbek
Jul 26, 2011·American Journal of Obstetrics and Gynecology·Christopher S EnnenErnest M Graham
Apr 9, 2011·Brain, Behavior, and Immunity·Cindy T J van VelthovenCobi J Heijnen
Apr 2, 2015·Current Opinion in Anaesthesiology·Katherine Louise Shea, Arvind Palanisamy
Aug 31, 2011·The Journal of Pediatrics·Rosemary D HigginsUNKNOWN Eunice Kennedy Shriver National Institute of Child Health and Human Development Hypothermia Workshop Speakers and Moderators
Aug 15, 2014·Frontiers in Cellular Neuroscience·Cindy T J van VelthovenDonna M Ferriero
Dec 9, 2017·Reviews in the Neurosciences·Suleiman Alhaji MuhammadSharida Fakurazi
Oct 28, 2017·Translational Stroke Research·Deepaneeta SarmahPallab Bhattacharya
Oct 29, 2017·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Clémence DisdierBarbara S Stonestreet
Jan 1, 2013·Brain Sciences·Felipe Goñi de CerioEnrique Hilario
Jan 1, 2013·Brain Sciences·David Fernández-LópezJosé Martínez-Orgado
Sep 27, 2018·Neurochemical Research·Eduardo Farias SanchesCarlos Alexandre Netto

❮ Previous
Next ❯

Methods Mentioned

BETA
genetic modifications

Clinical Trials Mentioned

NCT00593242

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.